| P2093 | author name string | Jean-Claude Bisserbe | |
| | Sabrina Paterniti | |
| P2860 | cites work | Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 |
| | Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 |
| | The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. | Q30587195 |
| | Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. | Q30956433 |
| | Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. | Q31136631 |
| | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis | Q33529314 |
| | Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 |
| | The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. | Q33969206 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | Q34098311 |
| | Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009. | Q34245595 |
| | Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 |
| | Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? | Q34503731 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania | Q34531273 |
| | Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs | Q45334862 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 |
| | Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. | Q45927642 |
| | Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. | Q46037763 |
| | Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study | Q46055220 |
| | Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants | Q46055681 |
| | Use of health care services among persons who screen positive for bipolar disorder | Q46064947 |
| | Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study | Q46634654 |
| | Current management of bipolar affective disorder: is it reflective of the BAP guidelines? | Q46713324 |
| | Adherence to guidelines by French psychiatrists in their real world of clinical practice | Q46715587 |
| | Impact of an educational program on the management of bipolar disorder in primary care | Q46806892 |
| | The role of monoamine oxidase inhibitors in depression treatment guidelines | Q47178085 |
| | Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients | Q48431874 |
| | Bipolar depression: clinical correlates of receiving antidepressants | Q48715901 |
| | Strategies for increasing treatment adherence in bipolar disorder | Q48716924 |
| | Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. | Q50929769 |
| | Correlates of suicidal ideation in dysphoric mania. | Q51083618 |
| | Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. | Q51899995 |
| | Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders. | Q51907203 |
| | Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. | Q51918015 |
| | Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. | Q51949078 |
| | Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 |
| | Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? | Q57612596 |
| | Changes in Pharmacological treatment for Bipolar Disorder Over Time in Manchester: A Comparison with Lloyd et al. (2003) | Q60621644 |
| | A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients | Q71496543 |
| | Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association | Q72850842 |
| | Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines | Q74502624 |
| | Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders | Q79535158 |
| | Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression | Q80777607 |
| | A successful effort to improve adherence to treatment guidelines for bipolar disorder | Q81494991 |
| | Closing the gap between guidelines for bipolar disorder treatment and clinical practice | Q84833724 |
| | Practice guideline for the treatment of patients with bipolar disorder (revision) | Q95789383 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment | Q34550618 |
| | The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. | Q34587132 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. | Q34588960 |
| | Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis | Q34604108 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | Q34616633 |
| | Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. | Q34633988 |
| | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression | Q35024109 |
| | The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder | Q35041599 |
| | Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 |
| | The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better | Q35180804 |
| | Pharmacotherapy for the treatment of acute bipolar II depression: current evidence | Q35954969 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies | Q36161335 |
| | The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. | Q36192638 |
| | Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. | Q37110231 |
| | Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks | Q37283773 |
| | Mania associated with antidepressant treatment: comprehensive meta-analytic review | Q37643765 |
| | Bipolar depression: overview and commentary | Q37736509 |
| | Predicting the course and outcome of bipolar disorder: a review | Q37742880 |
| | New treatment guidelines for acute bipolar depression: a systematic review | Q37764207 |
| | Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? | Q37775167 |
| | Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis | Q37804942 |
| | Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling | Q37960184 |
| | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry | Q38012647 |
| | Adherence to Turkish psychiatric association guideline for bipolar depression treatment in a specialized mood disorders outpatient unit. | Q39737756 |
| | Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany | Q39802523 |
| | Factors associated with treatment nonadherence among US bipolar disorder patients | Q40146888 |
| | Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study | Q42648497 |
| | Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial | Q42655788 |
| | Treatment of bipolar affective disorder in clinical practice | Q43558680 |
| | Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians | Q43585532 |
| | Quality of care in a Medicaid population with bipolar I disorder | Q43675485 |
| | Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004. | Q43737585 |
| | Use or underuse of therapeutic guidelines in psychiatry? | Q43860050 |
| | Trends in the treatment of bipolar disorder by outpatient psychiatrists | Q44013090 |
| | Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project | Q44271371 |
| | Pharmacotherapy patterns in the treatment of bipolar disorder | Q44272762 |
| | Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | Q45220527 |
| | Racial differences in the treatment of veterans with bipolar disorder | Q45332923 |
| P921 | main subject | pharmacotherapy | Q701216 |
| | bipolar disorder | Q131755 |
| P304 | page(s) | 211 | |
| P577 | publication date | 2013-08-13 | |
| P1433 | published in | BMC Psychiatry | Q15750257 |
| P1476 | title | Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service | |
| P478 | volume | 13 | |